Paradigm Shift in T1D treatment
May 23, 2017 20:49:29 GMT -5
liane, agedhippie, and 1 more like this
Post by jlaw277 on May 23, 2017 20:49:29 GMT -5
I think that giant pharmaceutical companies have worn out their welcome in this country, but the myriad of rules and regulations enacted by former U.S. Congresses and Executive Administrations for decades have stifled a free market economy and enabled BPs and BPMs to rake in enormous profits at the expense of families who are force to pay an unacceptably high price for drugs.
Behemoths like Amazon and Apple may pull off what our government has either been too corrupt or too inept to accomplish - an entirely new low cost healthcare system. I am not making a political statement, but simply observing that the current Administration's goal of streamlining, simplifying and modernizing FDA requirements could open the door to an entirely new model of health care system in the USA.
Amazon, like Apple, has enormous resources to cut out the middle man and drive down costs. Insurance companies, hospitals and patient advocates will fully endorse this new system for delivering lowest-priced drugs. PBMs may be on the way out.
Perhaps MannKind will one day be commended for recognizing change and leading the way in defiance of an antiquated and ineffective system.
"The drug-sales model is a wasteful scheme. Policy makers are seeking legislative remedies like compulsory reporting of rebates, or even tacit price controls. But the system will game around whatever regulatory rituals Congress divines. The scheme will end when drug makers realize that the current selling model is no longer in their economic interest, and when all of the system’s players realize that they’re losing their compact with patients. Then they’ll find a more honest and transparent way to sell medicines, without all of the secreted strings and rebates." - Scott Gottlieb